Lineage Cell Therapeutics Inc (AMEX:LCTX) traded at $0.92 at close of the session on Friday, June 20 and made an upward move of 0.95% on its previous day’s price.
Looking at the stock we see that its previous close was $3.92 and the beta (5Y monthly) reads 1.524 with the day’s price range being $0.8625 – $0.95. In terms of its 52-week price range, LCTX has a high of $1.15 and a low of $0.37. The company’s stock has gained about 95.63% over that past 30 days.
Lineage Cell Therapeutics Inc has a market cap of $216.94 million and is expected to release its quarterly earnings report on 2025-May-13.
Looking further, we note the current price level is 77 off its SMA20 and 0.01 from its 50-day simple moving average. The beta value is -24.00%, while the average true range (ATR) is currently pointing at -3.07%.
Coming back to Lineage Cell Therapeutics Inc (AMEX:LCTX), we note that the average 3-month trading volume was 2.55, while that of the preceding 10-day period stands at 3.4 million. Current shares outstanding are 228.36 million.
The insiders hold 0.44% of the company’s shares while institutions hold 48.65%. The data shows that short shares as of 2025-05-30, stood at 29.41 million at a short ratio of 36.23. This represents a 2298.00 short interest in shares outstanding on 2025-05-30. Shares short fall in May from the previous month at 30.0 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 4.96% up in year-to-date price movement.
